This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Agency for Science, Technology and Research. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Kun Liang: Innovator in Anti-Cancer Delivery Systems
Introduction
Kun Liang is a prominent inventor based in Singapore, known for his significant contributions to the field of medical technology. His innovative work focuses on developing advanced delivery systems for anti-cancer agents, which hold the potential to improve treatment efficacy.
Latest Patents
Kun Liang holds a patent for an "Anti-cancer agent delivery vehicle capable of improved loading." This invention involves a conjugate of a delivery agent that contains a chemical moiety and at least one flavonoid. The flavonoid can exist in either a monomeric or dimeric form before and after conjugation. Notably, the conjugate may comprise two flavonoids, and the delivery agent is conjugated at the C6 and/or C8 position of the A ring of the flavonoid. Additionally, the invention includes an anti-cancer agent delivery vehicle that combines an anti-cancer agent with the conjugate.
Career Highlights
Kun Liang is affiliated with the Agency for Science, Technology and Research, where he continues to push the boundaries of research and innovation in cancer treatment. His work is characterized by a commitment to enhancing the effectiveness of therapeutic agents through innovative delivery mechanisms.
Collaborations
Kun Liang collaborates with esteemed colleagues such as Motoichi Kurisawa and Susi Tan, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kun Liang's contributions to the field of anti-cancer delivery systems exemplify the impact of innovative thinking in medical research. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
